Engineers Gate Manager LP lifted its holdings in shares of Celanese Corporation (NYSE:CE – Free Report) by 2,657.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 124,083 shares of the basic materials company’s stock after acquiring an additional 119,583 shares during the period. Engineers Gate Manager LP’s holdings in Celanese were worth $5,708,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Geneos Wealth Management Inc. increased its position in Celanese by 111.1% in the 2nd quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company’s stock valued at $28,000 after acquiring an additional 270 shares during the period. National Bank of Canada FI acquired a new stake in shares of Celanese during the third quarter worth $34,000. Smartleaf Asset Management LLC grew its position in Celanese by 100.0% in the 2nd quarter. Smartleaf Asset Management LLC now owns 662 shares of the basic materials company’s stock valued at $38,000 after buying an additional 331 shares during the last quarter. UMB Bank n.a. increased its stake in Celanese by 175.7% in the 4th quarter. UMB Bank n.a. now owns 896 shares of the basic materials company’s stock valued at $38,000 after buying an additional 571 shares during the period. Finally, Kestra Advisory Services LLC acquired a new position in Celanese in the 4th quarter valued at $41,000. Hedge funds and other institutional investors own 98.87% of the company’s stock.
Wall Street Analysts Forecast Growth
CE has been the subject of several recent analyst reports. BMO Capital Markets reduced their target price on shares of Celanese from $57.00 to $54.00 and set a “market perform” rating for the company in a research note on Wednesday, August 5th. Wall Street Zen lowered shares of Celanese from a “buy” rating to a “hold” rating in a research note on Saturday, June 20th. KeyCorp began coverage on shares of Celanese in a report on Thursday. They set an “overweight” rating and a $57.00 price target for the company. Deutsche Bank Aktiengesellschaft set a $50.00 price objective on shares of Celanese in a research report on Thursday, August 6th. Finally, Mizuho set a $50.00 target price on Celanese in a research report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Celanese currently has a consensus rating of “Moderate Buy” and a consensus target price of $63.27.
Insiders Place Their Bets
In other news, SVP Mark Murray acquired 2,153 shares of Celanese stock in a transaction that occurred on Tuesday, August 11th. The shares were acquired at an average price of $45.52 per share, with a total value of $98,004.56. Following the completion of the purchase, the senior vice president owned 30,432 shares of the company’s stock, valued at approximately $1,385,264.64. This represents a 7.61% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.34% of the company’s stock.
Celanese Stock Up 1.0%
CE stock opened at $46.18 on Friday. The company’s 50 day simple moving average is $45.52 and its 200-day simple moving average is $52.76. The firm has a market capitalization of $5.07 billion, a PE ratio of -4.32, a P/E/G ratio of 0.30 and a beta of 0.76. Celanese Corporation has a 12 month low of $35.13 and a 12 month high of $70.70. The company has a debt-to-equity ratio of 2.33, a current ratio of 1.45 and a quick ratio of 0.87.
Celanese (NYSE:CE – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.22. Celanese had a positive return on equity of 13.04% and a negative net margin of 12.04%.The firm had revenue of $2.75 billion during the quarter, compared to the consensus estimate of $2.75 billion. During the same period in the previous year, the firm posted $1.44 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. Celanese has set its Q3 2026 guidance at 1.350-1.750 EPS. Equities analysts expect that Celanese Corporation will post 5.99 earnings per share for the current fiscal year.
Celanese Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, August 10th. Investors of record on Tuesday, July 28th were paid a $0.03 dividend. The ex-dividend date of this dividend was Tuesday, July 28th. This represents a $0.12 annualized dividend and a yield of 0.3%. Celanese’s payout ratio is presently -1.12%.
Key Stories Impacting Celanese
Here are the key news stories impacting Celanese this week:
- Positive Sentiment: KeyCorp upgraded Celanese to “Strong Buy,” reinforcing its bullish view on the chemicals company. KeyCorp maintains a $57 price target, implying meaningful upside from current levels. Celanese upgraded by KeyCorp
- Positive Sentiment: KeyCorp’s earnings outlook points to a recovery. The firm estimates $1.56 in third-quarter 2026 EPS, $1.19 in the fourth quarter, $6.10 for fiscal 2027 and $6.70 for fiscal 2028. The longer-term estimates exceed the current full-year consensus of $5.99, supporting the case that earnings could improve over time.
- Positive Sentiment: Unusually heavy call-option activity signals increased speculative interest in Celanese. Traders purchased 10,136 calls, roughly 410% above typical volume, suggesting some market participants are positioning for a rebound, though options activity is not a fundamental indicator.
- Neutral Sentiment: Celanese is selling another 19% of Nutrinova for $152 million, reducing its ownership stake to 11%. The proceeds could help the highly leveraged company pay down debt, but the transaction also reduces exposure to a business that could provide future growth. Celanese selling another 19% of Nutrinova
- Negative Sentiment: Recent coverage highlighted weakness following second-quarter 2026 results and the Nutrinova stake sale. Investors may remain cautious until Celanese demonstrates sustained earnings improvement and debt reduction. Celanese stock edges lower after earnings and Nutrinova sale
Celanese Profile
Celanese Corporation is a global chemical and specialty materials company headquartered in Irving, Texas. The company develops and manufactures engineered polymers, specialty chemicals and other materials used in a broad range of industries, including automotive, medical, electronics, consumer products, industrial equipment, coatings and packaging.
Celanese operates through two primary businesses: Engineered Materials and the Acetyl Chain. Its engineered materials portfolio includes high-performance thermoplastics, engineered polymers and other specialty compounds used to replace metal and conventional materials in demanding applications.
Further Reading
- Five stocks we like better than Celanese
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Want to see what other hedge funds are holding CE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celanese Corporation (NYSE:CE – Free Report).
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.
